(CHO) cells have demonstrated that the selective σ 1 R ligands PRE-084 and (+)pentazocine can dose-dependently cause the dissociation of σ 1 R from a binding immunoglobulin protein/78 kDa glucose-regulated protein (BiP/GRP-78), another ER chaperone [8, 26] . Thus, they serve as agonists. In contrast, the σ 1 R ligands haloperidol and 4-methoxy-3-(2-phenylethoxy)-N,N-dipropylbenzeneethanamine (NE-100) alone do not affect the σ 1 R-BiP association but both completely inhibit the dissociation of σ 1 R from BiP caused by (+)pentazocine: they serve as antagonists [8, 26] . In vivo, however, there is--as yet--no established functional assay for the σR subtypes. However, there is evidence showing a dose-dependent antagonism in vivo using the in vitro σ 1 R antagonists against the in vitro σ 1 R agonists using drug self-administration procedures [7, 12, 27, 28] . Thus, it appears that the in vitro agonist-antagonist relationship will apply some in vivo responses.
The [ 3 H] (+)-pentazocine-inaccessible σR, the σ 2 R, is an 18-21 kDa protein that has not been cloned yet [3, 20, [29] [30] [31] . However, a previous study using the radioligands [ 3 H](+)-pentazocine, and [ 3 H]DTG (in the presence of dextrallorphan) and a Flotillin-2 dotblotting technique in rat liver membranes found that σ 2 Rs are primarily localized in membrane lipid rafts whereas the σ 1 R localization appears in both raft and non-raft membrane domains [32] . The σ 1 R is dynamic and can translocate from its primary ER location to different subcellular compartments [24] . Previous mass spectrometry studies identified the σ2R-like proteins as being dimers consisting of H2A/H2B, the human nucleosomal proteins [33, 34] , which were defined using
) as a radioligand having a 19-fold higher affinity for the σ2 than for the σ1 receptors [35] . Abate et al. [34] showed that [ 3 H]PB28 accumulation was up to five-fold higher in nuclear fractions than in cytosolic fractions in SK-N-SH and MCF7 cells. However, the dimer differs from the σ 2 R in membrane association [32] . Thus, the identity of σ 2 Rs as nucleosomal proteins does not appear to be viable.
Due to the lack of a known σ 2 R amino acid sequence, photoaffinity labeling remains the most viable approach for visualizing the receptor using sodium dodecyl sulfate (SDS) gels [29] . The basic principle is to covalently combine a photoactivatable σ 2 R-binding probe with the receptor such that the probe (radioactive-or fluorescent-labeled) remains with the protein even after denaturation with SDS [29] . Using a novel photoaffinity probe for σ 2 Rs, WC-21, a recent study identified the σ 2 R as the PGRMC1 in rat livers [3] . For example, the non-selective σ 1/2 R ligand DTG prevented the photolabeling of PGRMC1 (with WC-21) [3] . Further, an immunocytochemical study revealed that both PGRMC1 and (1R,3r,5S)-9-(10-
, a fluorescent σ 2 R ligand, colocalize with molecular markers of the ER and mitochondria in HeLa cells [3] . As noted for the σ 1 R, studies utilizing various in vitro techniques indicated that σ 2 Rs are intracellular proteins.
However, the affinity of DTG for the PGRMC1 was not reported in the study [3] . Nonetheless, it appears that the identification of the σ 2 R as the PGRMC1 [3] has been accepted widely. However, two recent studies [1, 2] demonstrated a more viable data set against this identification as follows:
1.
The molecular size of PGRMC1 (25 kDa) is approximately 7 kDa higher than that of the σ 2 R (∼ 18 kDa) [4] . [4] or human MCF7 adenocarcinoma cell lines [5] which are devoid of the σ 1 R [36] .
4.
Progesterone has been reported to be a high-affinity (Kd=35 nM) ligand for PGRMC1 (Table 1) . However, the Ki value of progesterone for the σ 2 R [4] is approximately 406-fold higher than the Kd value for PGRMC1 in rat liver membranes (Table 1) . Further, the Ki value of DTG for the PGRMC1 is 472,000 ± 420,000 nM (Table 1 ) using cold (+)-pentazocine to block the σ 1 R [4] , which is approximately 15,000-fold higher than that for the σ 2 R [4] ( Table  1) . However, the Ki value of DTG for the PGRMC1 [4] was shown to be >1,000-fold lower than that obtained in a previous study [37] (Table 1) . This discrepancy likely results from the lack of use of a selective cold blocker at the σ 1 R in the previous study [37] since DTG can also bind the σ 1 R with high affinity (Table 1 ). The binding profile of DTG for the PGRMC1 has been consistent with that for haloperidol, another non-selective σ1/2R ligand [4] ( Table 1) . Thus, the PGRMC1 is not a high-affinity DTG binding site, which also means that the PGRMC1 is not the σ 2 R.
Together, these new data [4, 5] clearly suggest that the σ 2 R and PGRMC1 are two different molecular entities. Furthermore, the photo affinity probe containing a σ 2 R-directing moiety that led to the identification of PGRMC1 [3] as the σ 2 R (with WC-21), likely binds both σ 2 R and PGRMC1. The identification of the σ 2 R as distinct from the PGRMC1 [4, 5] should have considerable impact especially in the cancer study field since the σ 2 R has been developed as a biomarker for various tumor cells [38] . Other studies have attempted to examine the correlation between the binding affinity of various σR ligands and their ability to produce effects both in vitro and in vivo through the σ 2 R [35, 39] . However, the evidence for σ 2 Rmediated actions from these studies is not compelling because of the mixed use of σR agonist-like and antagonist-like ligands. Thus, the pharmacology and physiological role of σ 2 Rs remain undetermined due to unsuccessful efforts to clone the receptor and a lack of activation of the σ 2 R resulted in the synthesis and release of dopamine in the rat brain [6, 7] . Thus, future studies that further explore σ 2 R pharmacology may result in a better understanding of the dopamine-mediated reinforcing mechanism associated with stimulant abuse and other dopamine-related diseases (e.g. Parkinson's disease and schizophrenia).
